This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...
This is a $76,461 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Translational Technologies International, LLC, a self-certified small disadvantaged and woman-owned business. The contract is for a qualitative evaluation of the CDC's Prevention Research Center Program network. The award is under the CDC's Technical and Management Support for Health Promotion Activities contract vehicle. There is no set-aside designation for this contract, and...
This is a $749,767.14 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Technology & Business Management Inc. (TBMUS), an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for OIGA Operational and Data Services, with a period of performance through January 8, 2025. This award is a sole-source set-aside for 8(a) firms. TBMUS is a Virginia-based small business that provides digital...
The Centers for Disease Control and Prevention (CDC) awarded a $5,176,985.37 cost-no-fee definitive contract to King County, doing business as Public Health-Seattle & King County, to develop and evaluate interventions for identifying and treating latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. This contract, titled "TBESC 3 - Seattle and King County," does not have a set-aside designation, indicating it was competed on a full...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) with a ceiling value of $1,154,591.00. The contract was awarded to the prime contractor, Research Triangle Institute (RTI International), a non-profit research organization. The contract is a Blanket Purchase Agreement call for "Other Functions Prep and Pep" and does not have a set-aside designation. Major subcontractors include Ipsos Public Affairs, LLC, a global market research firm, and...
<p>This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Carrera Bioscience Inc., a woman-owned small business, for critical functions. The contract has a ceiling value of $150,000.00 and a period of performance ending on March 20, 2016. The contract was set aside for total small business participation.</p>
<p>This TBTC-3 contract was awarded on September 13, 2002 by the Centers for Disease Control and Prevention in Atlanta, Georgia to an undisclosed prime contractor. The potential value of the contract is $15,828,299. It has a completion date of November 12, 2010 and is a definitive cost-no-fee contract for undefined services to be performed in Atlanta. No set-aside provision was used for this award made under the auspices of the Department of Health and Human Services.</p>